⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20200727 | 0.81 | — | — | |
| SCHEMBL22332871 | 0.81 | — | — | |
| SCHEMBL20200130 | 0.81 | — | — | |
| SCHEMBL20200719 | 0.81 | — | — | |
| SCHEMBL20200726 | 0.81 | — | — | |
| Fluoride SCHEMBL11473571 | 0.80 | TRPV1 (0.33) | — | |
| Hydrochloric Acid SCHEMBL11327617 | 0.80 | TRPV1 (0.33) | — | |
| SCHEMBL6948738 | 0.79 | TSHR (0.40) | — | |
| SCHEMBL23905170 | 0.77 | TRPV1 (0.35) | — | |
| SCHEMBL24277071 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 538 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115066238-A | Preparation of cannabichromenes and related cannabinoids | 海湾医学公司 | 2022-09-16 | — | — | CN | claimed |
| CN-1922324-B | Bacterial virulence factors and uses thereof | UNIV BRITISH COLUMBIA | 2010-06-09 | — | — | CN | claimed |
| EP-1572074-A4 | STABILIZED SYNTHETIC IMMUNOGEN DELIVERY SYSTEM | UNITED BIOMEDICAL INC (US) | 2008-04-30 | — | — | EP | claimed |
| EP-1465639-A4 | ADJUVANT FORMULATIONS FOR BACTERIAL AND VIRUS VACCINES AND METHOD OF MAKING SAME | IRX THERAPEUTICS INC (US) | 2006-05-24 | — | — | EP | claimed |
| EP-1572074-A2 | STABILIZED SYNTHETIC IMMUNOGEN DELIVERY SYSTEM | United Biomedical, Inc. (US) | 2005-09-14 | — | — | EP | claimed |
| US-20050148538-A1 | Adjuvant formulations for bacterial and virus vaccines and method of making same | IRX THERAPEUTICS, INC. | 2005-07-07 | — | — | US | claimed |
| EP-1465639-A2 | ADJUVANT FORMULATIONS FOR BACTERIAL AND VIRUS VACCINES AND METHOD OF MAKING SAME | Immuno-RX, Inc. (US) | 2004-10-13 | — | — | EP | claimed |
| EP-1092737-B1 | Catalyst composition for the production of a polyurethane resin, and method for producing a polyurethane resin | TOSOH CORP (JP) | 2003-09-24 | — | — | EP | claimed |
| WO-2003068169-A2 | STABILIZED SYNTHETIC IMMUNOGEN DELIVERY SYSTEM | UNITED BIOMEDICAL INC. (US) | 2003-08-21 | — | — | WO | claimed |
| WO-2003049670-A2 | ADJUVANT FORMULATIONS FOR BACTERIAL AND VIRUS VACCINES AND METHOD OF MAKING SAME | IMMUNO-RX, INC. (US) | 2003-06-19 | — | — | WO | claimed |
| US-12042531-B2 | Breast and ovarian cancer vaccines | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2024-07-23 | — | — | US | disclosed |
| CN-114504640-B | Adjuvant containing risedronate zinc-aluminum and application thereof | 厦门大学 | 2024-06-25 | — | — | CN | disclosed |
| US-20240050553-A1 | MAKING INFLUENZA VIRUS VACCINES WITHOUT USING EGGS | Seqirus UK Limited (GB) | 2024-02-15 | — | — | US | disclosed |
| US-11896660-B1 | Reducing hospitalization in elderly influenza vaccine recipients | Seqirus UK Limited (GB) | 2024-02-13 | — | — | US | disclosed |
| US-20240034773-A1 | RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-02-01 | — | — | US | disclosed |
| EP-0681470-A1 | RECOMBINANT LIVING SUBUNIT VACCINE COMPOSITION AND PROCESS FOR ITS PREPARATION. | SEPPIC SA (FR) | 1995-11-15 | — | — | EP | disclosed |
| WO-1994016681-A1 | RECOMBINANT LIVING SUBUNIT VACCINE COMPOSITION AND PROCESS FOR ITS PREPARATION | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES, S.E.P.P.I.C (FR) | 1994-08-04 | — | — | WO | disclosed |
| EP-0527977-A4 | NEMATODE VACCINE | — | 1993-08-11 | — | — | EP | disclosed |
| EP-0527977-A1 | NEMATODE VACCINE. | BIOTECH AUSTRALIA PTY LTD (AU) | 1993-02-24 | — | — | EP | disclosed |
| WO-1992013889-A1 | NEMATODE VACCINE | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1992-08-20 | — | — | WO | disclosed |